Measuring Aided Language Development
MALD
2 other identifiers
interventional
60
1 country
1
Brief Summary
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
May 16, 2025
May 1, 2025
3 years
July 16, 2024
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aided AAC Utterance Length
Aided AAC Sentence Length Measured in Morphemes
24 Months
Study Arms (1)
Treatment Group
EXPERIMENTALAAC Generative Language Intervention
Interventions
Aided AAC Language Input/Output Intervention
Eligibility Criteria
You may qualify if:
- Clinical Identification of Down Syndrome or Cerebral Palsy + Significant Speech Impairment
- Must Speak English as a Primary Language
- Must Be Able to Express At Least 25 Words (using any communication mode)
- Must Be Able to Accurately Select Picture Symbols on iPad Communication App with at Least 50% Accuracy
- Vision and Hearing within Functional Limits or Corrected to be within Functional Limits for Study Activities
You may not qualify if:
- Clinical Diagnosis of Autism or Social Communication Disorder
- Primary Language Spoken is A Language Other than English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Central Floridalead
- National Institute on Deafness and Other Communication Disorders (NIDCD)collaborator
- University of New Mexicocollaborator
- University of Wisconsin, Milwaukeecollaborator
Study Sites (1)
University of Central Florida - Innovative Center
Orlando, Florida, 32826, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pegasus Professor & Associate Dean of Research
Study Record Dates
First Submitted
July 16, 2024
First Posted
July 22, 2024
Study Start
April 1, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 31, 2028
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
NICHD Data and Specimen Hub